#VisualAbstract: Induction chemotherapy with concurrent chemoradiotherapy may improve survival in intermediate-risk pediatric patients with nasopharyngeal carcinoma

byTeddy Guo

February 2, 2022

in StudyGraphics

Reading Time: 1 min read

Tofacitinib increases cardiovascular and cancer risk in rheumatoid arthritis

RelatedReports

Paternal factors associated with short interpregnancy interval

Infectious Disease

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

March 29, 2023

No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer

Chronic Disease

Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma

March 29, 2023

Pimecrolimus effective first-line treatment for atopic dermatitis

Chronic Disease

Lebrikizumab effective in treating moderate-to-severe atopic dermatitis

March 29, 2023

Nivolumab may be effective in platinum-resistant ovarian cancer

Obstetrics

Immediate postpartum opioid administration not associated with adverse infant outcomes

March 28, 2023

Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial

Angiotensin II receptor type 2 and 4-stimulating antihypertensives associated with reduced long-term cognitive impairment compared to receptor inhibitors

Many new pediatric asthma cases attributable to obesity

Semaglutide and phentermine-topiramate are effective weight reducing medications

Parental hopes for critically ill children are dynamic

Moderate hypothermia during venoarterial extracorporeal membrane oxygenation not associated with a decrease in 30-day mortality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Induction chemotherapy with concurrent chemoradiotherapy may improve survival in intermediate-risk pediatric patients with nasopharyngeal carcinoma

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma

Lebrikizumab effective in treating moderate-to-severe atopic dermatitis

Tofacitinib increases cardiovascular and cancer risk in rheumatoid arthritis

Angiotensin II receptor type 2 and 4-stimulating antihypertensives associated with reduced long-term cognitive impairment compared to receptor inhibitors

RelatedReports

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma

Lebrikizumab effective in treating moderate-to-severe atopic dermatitis

Immediate postpartum opioid administration not associated with adverse infant outcomes

Angiotensin II receptor type 2 and 4-stimulating antihypertensives associated with reduced long-term cognitive impairment compared to receptor inhibitors

Semaglutide and phentermine-topiramate are effective weight reducing medications

Moderate hypothermia during venoarterial extracorporeal membrane oxygenation not associated with a decrease in 30-day mortality

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: Induction chemotherapy with concurrent chemoradiotherapy may improve survival in intermediate-risk pediatric patients with nasopharyngeal carcinoma

RELATED REPORTS

Tofacitinib increases cardiovascular and cancer risk in rheumatoid arthritis

Angiotensin II receptor type 2 and 4-stimulating antihypertensives associated with reduced long-term cognitive impairment compared to receptor inhibitors

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?